Abstract
Background and Aims: Pathogenic bacteria and host cells counteract or neutralize each other's effect in two fundamental ways: Direct invasion and secretion of various substances. Among these, lipases secreted by pathogenic bacteria and host cell lysozyme are key actors. Secreted lipases from pathogenic bacterial are suggested as a key player in the pathogen-host interaction. Among the gut microbial energy sources, glucose and fats have been referred to as one of the best inducers and substrates for bacterial lipases. Enrichment of bacterial growth medium with extra glucose or oil has been shown to induce lipase production in pathogenic bacteria. More recently, research has focused on the role of human gut phage alterations in the onset of dysbiosis because the bacteria-phage interactions can be dramatically affected by the nutrient milieu of the gut. However, the reciprocal role of bacterial lipases and phages in this context has not been well studied and there is no data available about how high glucose or fat availability might modulate the cellular milieu of the pathogenic bacteria-phage-eukaryotic host cell interface. The purpose of this study was to evaluate the immunologic outcome of pathogenic bacteria- phage interaction under normal, high glucose, and high butter oil conditions to understand how nutrient availability affects lipase activity in pathogenic bacteria and, ultimately, the eukaryotic host cell responses to pathogenic bacteria-phage interaction.
Materials and Methods: 10 groups of co-cultured T84 and HepG2 cells were treated with Pseudomonas aeruginosa strain PAO1 (P.a PAO1) in the presence and absence of its KPP22 phage and incubated in three different growth media (DMEM, DMEM + glucose and DMEM + butter oil). Structural and physiological (barrier function and cell viability), inflammatory (IL-6 and IL-8), metabolic (glucose and triglycerides), and enzymatic (lipases and lysozyme) parameters were determined.
Results: Excess glucose or butter oil enhanced additively extracellular lipase activity of P.a PAO1. Excess glucose or butter oil treatments also magnified P. a PAO1- induced secretion of inflammatory signal molecules (IL-1β, IL-6) from co-cultured cells, concomitant with the enhancement of intracellular triglycerides in co-cultured HepG2 cells, these effects being abolished by phage KPP22.
Conclusion: The results of the present study imply that KPP22 phage influences the interplay between food substances, gut bacterial lipases, and the gut cellular milieu. This can be applied in two-way interaction: by affecting the microbial uptake of excess free simple sugars and fats from the gut milieu leading to decreased bacterial lipases and by modulating the immune system of the intestinal -liver axis cells. Further studies are needed to see if the biological consequences of these effects also occur in vivo.
Graphical Abstract
[http://dx.doi.org/10.1186/s12934-020-01428-8] [PMID: 32847584]
[http://dx.doi.org/10.1007/s00253-004-1568-8] [PMID: 14966663]
[http://dx.doi.org/10.1002/hep.31250] [PMID: 32236963]
[http://dx.doi.org/10.1038/s41598-020-62427-8] [PMID: 32214208]
[http://dx.doi.org/10.1006/fmic.1996.0044]
[http://dx.doi.org/10.1016/0141-0229(93)90062-7] [PMID: 7763958]
[http://dx.doi.org/10.1007/BF00872935] [PMID: 7574552]
[http://dx.doi.org/10.1111/j.1745-4514.2007.00140.x]
[http://dx.doi.org/10.3390/ijms21144929] [PMID: 32668581]
[http://dx.doi.org/10.1128/iai.64.8.3252-3258.1996] [PMID: 8757861]
[http://dx.doi.org/10.1007/s00284-021-02589-4] [PMID: 34279672]
[http://dx.doi.org/10.1101/2020.09.08.287425]
[http://dx.doi.org/10.1073/pnas.1817248116] [PMID: 30755523]
[http://dx.doi.org/10.1057/s41599-020-0478-4]
[http://dx.doi.org/10.3390/antibiotics8030131] [PMID: 31461990]
[http://dx.doi.org/10.1038/s41385-019-0250-5] [PMID: 31907364]
[http://dx.doi.org/10.2174/1871530322666220408215101]
[http://dx.doi.org/10.3390/microorganisms8122012] [PMID: 33339331]
[http://dx.doi.org/10.3389/fcimb.2022.915099] [PMID: 35719361]
[http://dx.doi.org/10.1128/AEM.00090-16] [PMID: 27208109]
[http://dx.doi.org/10.1128/JB.01515-09] [PMID: 20023018]
[http://dx.doi.org/10.1089/sur.2011.063] [PMID: 23451729]
[http://dx.doi.org/10.1016/j.biortech.2011.09.076] [PMID: 22004595]
[http://dx.doi.org/10.1016/j.biortech.2007.09.053] [PMID: 17976982]
[http://dx.doi.org/10.7717/peerj.2261] [PMID: 27547567]
[http://dx.doi.org/10.1038/s41596-020-0346-0] [PMID: 32709990]
[http://dx.doi.org/10.1002/ibd.21057] [PMID: 19714766]
[http://dx.doi.org/10.1007/s00418-017-1539-7] [PMID: 28265783]
[http://dx.doi.org/10.1002/mnfr.202100456] [PMID: 34787358]
[http://dx.doi.org/10.1111/mmi.14844] [PMID: 34783412]
[http://dx.doi.org/10.1038/s41467-021-24632-5] [PMID: 34262037]
[http://dx.doi.org/10.1016/j.jksus.2017.12.018]
[http://dx.doi.org/10.1016/j.ejbt.2021.07.003]
[http://dx.doi.org/10.1128/jb.138.3.663-670.1979] [PMID: 222724]
[http://dx.doi.org/10.1128/AEM.71.7.3468-3474.2005] [PMID: 16000750]
[http://dx.doi.org/10.1007/s12639-011-0066-z] [PMID: 23542635]
[http://dx.doi.org/10.3390/molecules24040715] [PMID: 30781467]
[http://dx.doi.org/10.3389/fimmu.2019.01266] [PMID: 31231388]
[http://dx.doi.org/10.1016/j.chom.2018.11.016] [PMID: 30658906]
[http://dx.doi.org/10.1136/gut.35.1_Suppl.S13] [PMID: 8125383]
[http://dx.doi.org/10.1101/cshperspect.a016295] [PMID: 25190079]
[http://dx.doi.org/10.1186/s41232-019-0101-5] [PMID: 31182982]
[http://dx.doi.org/10.3797/scipharm.1012-15] [PMID: 21773070]
[http://dx.doi.org/10.1053/j.gastro.2020.03.010] [PMID: 32169430]
[http://dx.doi.org/10.1007/s00253-015-7041-z] [PMID: 26476653]
[http://dx.doi.org/10.1128/jb.168.3.1070-1074.1986] [PMID: 3096967]
[http://dx.doi.org/10.1016/j.immuni.2014.12.028] [PMID: 25607457]
[http://dx.doi.org/10.1016/j.cell.2021.01.029] [PMID: 33606979]
[http://dx.doi.org/10.3390/pathogens3010073] [PMID: 25437608]
[http://dx.doi.org/10.3389/fcimb.2021.643214] [PMID: 34150671]
[http://dx.doi.org/10.1038/nrm2330] [PMID: 18216768]
[http://dx.doi.org/10.1016/j.plipres.2009.07.003] [PMID: 19638285]